Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Distinct sensitivities to SARS-CoV-2 variants in vaccinated humans and mice

Cell Reports(2022)10.1016/j.celrep.2022.111299Source: DataRank Database

Distinct sensitivities to SARS-CoV-2 variants in vaccinated humans and mice is a research paper published in Cell Reports (2022). On theSindex it has a DataRank of 0.765. It has been cited 16 times, with 12 citing works in its 1-hop citation network.

N/A

0.765DataRank · unranked

Scored on demand from live citation data

Deposits data Open Access16 citations · 12 citing works in its network

Download PDF

Cite:

Linked data & code

nct

Data availability

Repositories this paper deposited data in (declared in PubMed).

ClinicalTrials.govNCT05007951

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (15 grants)OA: goldTopics (39)IDs (PubMed, PMC)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

DataRank Breakdown

Base Score 56%Citation Network 44%

Base Score Contribution

0.425

From this paper's citation signal

Citation Network Contribution

0.340

From 11 citing papers with measurable signal

Learn more about DataRank methodology →

Top 5 citers driving the network score

Ranked by each citer's contribution to N(p) — log1p(C_q) divided by its reference count — out of 12 citers.

An optimized messenger RNA vaccine candidate protects non-human primates from Zika virus infection
npj Vaccines202359 citations54 referencesContributes 0.076
Immunogenicity and protection of a variant nanoparticle vaccine that confers broad neutralization against SARS-CoV-2 variants
Nature Communications202320 citations49 referencesContributes 0.062
Mosaic RBD nanoparticles protect against challenge by diverse sarbecoviruses in animal models
Science2022288 citations95 referencesContributes 0.060
Comparison of media for a human peripheral blood mononuclear cell-based in vitro vaccine evaluation system
Clinical and Experimental Vaccine Research20237 citations37 referencesContributes 0.056
Preclinical immunogenicity and protective efficacy of a SARS-CoV-2 RBD-based vaccine produced with the thermophilic filamentous fungal expression system Thermothelomyces heterothallica C1
Frontiers in Immunology20235 citations34 referencesContributes 0.053

Authors (30)

Laura A. VanBlargan ORCID,Kaichun Wu ORCID,Angela Choi ORCID,Mary Jane Navarro,Diana Lee ORCID

Live enrichment

PubMed:35988541 PMC:PMC9376299

National Institute of Allergy and Infectious Diseases

Grant: 75N93021C00014

National Institute of Allergy and Infectious Diseases

Grant: DP1AI158186

National Institute of Allergy and Infectious Diseases

Grant: HHSN272201700059C

National Institute of Allergy and Infectious Diseases

Grant: R01 AI157155

Bill and Melinda Gates Foundation

Grant: OPP1156262

NIAID NIH HHS

Grant: U19 AI167903

NIH HHS

Grant: U42 OD011123

NIAID NIH HHS

Grant: U19 AI057266

NIH HHS

Grant: P51 OD010425

NIAID NIH HHS

Grant: U01 AI151698

National Institutes of Health

Grant: 5DP1AI158186-05

Unraveling the bat humoral immune response against zoonotic viruses to guide the design of next-generation therapeutics

National Institutes of Health

Grant: 5R01AI157155-02

Human antibody-based countermeasures against the Coronavirus SARS-CoV-2

National Institutes of Health

Grant: 3P51OD010425-53S1

Washington National Primate Research Center

National Institutes of Health

Grant: 2U42OD011123-10

WaNPRC Macaca nemestrina SPF Breeding Colony

Burroughs Wellcome Fund

goldLicense: CC BY NC ND

publisherhttps://api.elsevier.com/content/article/PII:S2211124722011196?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S2211124722011196?httpAccept=text/plain

Europe_PMChttps://europepmc.org/articles/PMC9376299

Europe_PMChttps://europepmc.org/articles/PMC9376299?pdf=render

https://doi.org/10.1016/j.celrep.2022.111299

Fields of Study

0301 basic medicine03 medical and health sciences

MeSH Terms

AnimalsMice, Inbred BALB CPrimatesHumansMiceViral VaccinesAntibodies, ViralAntibodies, NeutralizingSpike Glycoprotein, CoronavirusCOVID-19SARS-CoV-2

Keywords

AntibodiesVaccinesMouseNon-human primatesHumansCovid-19Sars-cov-2Cp: MicrobiologyCp: ImmunologyPrimatesMice, Inbred BALB C572ICTS (Institute of Clinical and Translational Sciences)Viral VaccinesAntibodies, ViralAntibodies, NeutralizingSpike GlycoproteinCoronavirusMiceReportSpike Glycoprotein, CoronavirusMedicine and Health SciencesAnimalsViralNeutralizingInbred BALB C

Sustainable Development Goals

SDG 3: 3. Good health